Candel Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.09

-0.06 (-0.66%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 87%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +423.5% upside

Low Target $33.44

Average Target $47.59

High Target $47.92

Current Price $9.09

Current
$9.09

Target
$47.59

$33.44 $47.59 avg $47.92

Scenario Analysis

Bear Case

$33.44

267.9%

Low target

Base Case

$47.59

+423.5%

Avg target

Bull Case

$47.92

+427.2%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$9.57

-5.0% from high

52-Week Low

$4.35

+109.0% from low

Target vs 52W High

$47.59

+397.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%